Genotipas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 118,483 | 87,597 | 66,485 | 178,231 | 654,645 | 52,753 | 301,406 | 479,499 |
| Profit before tax | 44,277 | -62,669 | -49,147 | 76,331 | 359,079 | -68,778 | -16,605 | -198,522 |
| Net profit | 37,635 | -62,669 | -49,147 | 75,938 | 314,913 | -73,458 | -16,605 | -198,522 |
| Equity | 41,101 | -21,568 | -70,715 | 5,223 | 309,737 | 236,279 | 219,674 | 21,152 |
| Liabilities | 25,498 | 86,944 | 158,717 | 96,179 | 126,414 | 2,158 | 6,140 | 146,512 |
| Non-current assets | 20,000 | 20,000 | 20,000 | 20,000 | 0 | 0 | 0 | 0 |
| Current assets | 46,549 | 45,376 | 68,002 | 81,402 | 436,151 | 238,437 | 225,814 | 169,605 |
| Total assets | 66,549 | 65,376 | 88,002 | 101,402 | 436,151 | 238,437 | 225,814 | 169,605 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 52,877 | 2,392 | - |
| Social insurance contributions | - | - | - | - | - | 10,440 | 9,766 | 25,949 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +5408.3% | -26.1% | -24.1% | +168.1% | +267.3% | -91.9% | +471.4% | +59.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 56.6% | -95.9% | -55.8% | 74.9% | 72.2% | -30.8% | -7.4% | -117.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 91.6% | - | - | 1453.9% | 101.7% | -31.1% | -7.6% | -938.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 31.8% | -71.5% | -73.9% | 42.6% | 48.1% | -139.2% | -5.5% | -41.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 37.4% | -71.5% | -73.9% | 42.8% | 54.9% | -130.4% | -5.5% | -41.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | - | - | 18.4 | 0.4 | 0.0 | 0.0 | 6.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,606 | 13,651 | 12,088 | 36,250 | 65,465 | 10,378 | 53,189 | 58,714 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Genotipas - Social security debts
The company had no debts to Sodra
Genotipas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Genotipas, UAB (code 304460006) is a Private Limited Liability Company engaged in research and experimental development on other natural sciences and engineering. In the latest financial year, 2025, the company generated revenue of EUR 479.5K, up 59.1% year on year and well above the EUR 52.8K reported in 2023. Revenue growth was accompanied by a much weaker bottom line: net loss widened to EUR 198.5K in 2025 from EUR 16.6K in 2024 and EUR 73.5K in 2023, leaving a negative profit margin of 41.4%. The balance sheet at year-end 2025 showed total assets of EUR 169.6K, equity of EUR 21.2K and liabilities of EUR 146.5K, indicating a low equity base and elevated leverage. The equity ratio stood at 12.5%, while asset turnover reached 2.83x. Revenue per employee was EUR 59.9K and profit per employee was negative. Overall, the company expanded strongly on the top line over the past two years, but profitability and capital structure weakened materially in 2025.